ENTITY
Mega Lifesciences

Mega Lifesciences (MEGA TB)

83
Analysis
Health Care • Thailand
Mega Lifesciences is a leading international pharmaceutical and nutraceutical company that manufactures, markets, sells, and distributes quality pharmaceutical products, medicinal supplements, and personal health products. The company also operates through its branded products segment, Mega We Care, and a distribution platform, Maxxcare, for third-party products. It is headquartered in Bangkok, Thailand, and was founded in 1982.
more
•12 Sep 2018 09:47•Broker

MEGA: Supplement Maker Spreads Healthy Message in Booming Region

We initiate coverage on MEGA with a BUY rating and based on a target price of Bt43, which is derived from the DCF methodology (WACC 12.5% and...

•05 Jul 2018 07:42

Little Thai-Coons of 2018 (Part 2): The New Industrialists

The other four new tycoons on Forbes are more difficult to group, because they come from such diverse set of industries. I guess we could pretty...

•27 Mar 2018 11:27

MEGA (MEGA TB): ASEAN and Africa Continue to Offer Mega Opportunities

Cheap on a gross profit basis, strong net profit momentum, and good price momentum relative to its sector Mega We Care (MWC) should continue to...

Share
•09 Jan 2018 12:37

MEGA (MEGA TB): Emerging Drug Opportunities to Spur Growth

Good price momentum, cheap on a gross profit basis, and good growth in core profit relative to its sector African pharmaceuticals market, a market...

Share
•02 Oct 2017 10:48

MEGA: Growing in Africa and Malaysia

Cheap on a gross profit basis, strong net profit, and good pricemomentum relative to its sector African pharmaceuticals market, a market growing...

Share
x